Prescribers’ perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis

Abstract

Background The indication for prescribing a particular medication, or its reason for use (RFU) is a crucial piece of information for all those involved in the circle of care. Research has shown that sharing RFU information with physicians, pharmacists and patients improves patient safety and patient adherence, however RFU is rarely added on prescriptions by prescribers or on medication labels for patients to reference. Methods Qualitative interviews were conducted with 20 prescribers in Southern Ontario, Canada, to learn prescribers’ current attitudes on the addition of RFU on prescriptions and medication labels. A trained interviewer used a semi-structured interview guide for each interview. The interviews explored how the sharing of RFU information would impact prescribers’ workflows and practices. Interviews were recorded, transcribed and thematically coded. Results The analysis yielded four main themes: Current Practice, Future Practice, Changing Culture, and Collaboration. Most of the prescribers interviewed do not currently add RFU to prescriptions. Prescribers were open to sharing RFU with colleagues via a regional database but wanted the ability to provide context for the prescribed medication within the system. Many prescribers were wary of the impact of adding RFU on their workflow but felt it could save time by avoiding clarifying questions from pharmacists. Increased interprofessional collaboration, increased patient understanding of prescribed medications, avoiding guesswork when determining indications and decreased misinterpretation regarding RFU were cited by most prescribers as benefits to including RFU information. Conclusions Prescribers were generally open to sharing RFU and clearly identified the benefits to pharmacists and patients if added. Critically, they also identified benefits to their own practices. These results can be used to guide the implementation of future initiatives to promote the sharing of RFU in healthcare teams.

Documenting the indication for antimicrobial prescribing: a scoping review

“…Similar barriers have also been identified: alert fatigue and prescribers overriding mandatory fields;140 time pressure141 and ambiguity in medication indications 142. An additional barrier is prescribers being hesitant to document indications due to concerns of patient privacy 141 143. For example, prescribers felt that documenting the indication on the prescription could increase patient anxiety or contribute to patients not accessing care (eg, for sexually transmitted infections), which could also be relevant to antibiotic prescriptions depending on the indication.…”

Electronic transmission of prescriptions in primary care: transformation, timing and teamwork

“…23,24 The inclusion of the indication on prescriptions is another communication opportunity, enabled by technology, that has been previously identified as helping pharmacists reinforce physicians' patient education. 9,25 Pharmacists and GPs both felt the opportunity for the systems to deliver transformation in prescription-related communication practices between prescribers and pharmacists was yet to be fully realised. Although some tools were built in, participants described pitfalls such as not knowing where messages ended up or when they had been read, and a limited number of interchanges.…”

Indication documentation and indication-based prescribing within electronic prescribing systems: a systematic review and narrative synthesis

“…Search terms included relevant synonyms, truncations and spelling alternatives. A test list of nine known papers11 13–20 was used to test the search strategy. Searches were conducted on Embase, Medline and CINAHL using relevant subject headings and keywords (online supplemental eTables 1–3) following advice from a subject librarian.…”